Weitere Artikel dieser Ausgabe durch Wischen aufrufen
The aim of this study was to investigate factors influencing mortality after percutaneous coronary intervention (PCI) in patients aged ≥ 75 years compared to younger patients.
A total of 1,809 coronary heart disease (CHD) patients after PCI with stent implantation in our hospital were assessed. Kaplan–Meier analyses with log-rank test and Cox regression analyses were performed on three predefined models concerning primary endpoint of all-cause mortality. Model 1 was a univariate analysis of the influence of age dichotomized by age 75 years on the primary endpoint. Model 2 included age and classical cardiovascular risk factors (CVRFs, e.g., body mass index (BMI), smoking, diabetes, and hypertension). Model 3 consisted of age, classical CVRFs, and additional factors (e.g., medication; hemoglobin, peripheral arterial disease (PAD), low-density lipoprotein cholesterol (LDL-C) and creatinine levels, and left ventricular ejection fraction (LVEF)).
In the mean follow-up of 137 ± 61 weeks 375 patients died. Age ≥ 75 years was significantly related to mortality in all models. In model 3, previous stroke, PAD, diabetes, elevated levels of serum creatinine, and increased LDL-C were related to elevated mortality, higher hemoglobin levels, and LVEF > 50% were associated with decreased mortality in all patients and in patients < 75 years. In patients ≥ 75 years arterial hypertension was associated with poor outcome (hazard ratio (HR) 7.989, p = 0.040), previous antiplatelet therapy showed reduced mortality (HR 0.098, p = 0.039).
Although risk factors such as previous stroke, PAD, diabetes, renal insufficiency, and anemia were predictors for death in all patients and patients < 75 years, in the elderly only arterial hypertension increased, whereas treatment with platelet inhibitors decreased mortality.
Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten
Sie möchten Zugang zu diesem Inhalt erhalten? Dann informieren Sie sich jetzt über unsere Produkte:
Chen B, Zhang D, Zhu T et al (2010) Immediate and long-term results of coronary angioplasty in patients aged 80 years and older. Cardiol Res Pract doi10.4061/2010/263685
Graham I, Atar D, Borch-Johnsen K et al (2007) European guidelines on cardiovascular disease prevention in clinical practice: Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice. Eur J Cardiovasc Prev Rehabil 14(Supp 2):1–113 CrossRef
Harris T, Cook EF, Kannel WB et al (1988) Proportional hazards analysis of risk factors for coronary heart disease in individuals aged 65 or older. The Framingham Heart Study. J Am Geriatr Soc 36:1023–1028 PubMed
Kannel WB, Gordan T (1978) Evaluation of cardiovascular risk in the elderly: the Framingham Study. Bull N Y Acad Med 54:573–591 PubMed
Kin K, Iwamoto T, Kanaya K, Takasaki M (2004) Platelet aggregation is significantly associated with cardiovascular mortality in elderly patients. Geriatr Gerontol Int 4:206–214 CrossRef
Veeranna V, Pradhan J, Niraj A et al (2010) Traditional cardiovascular risk factors and severity of angiographic coronary artery disease in the elderly. Prev Cardiol 13:135–140 PubMed
Willerson JT, Ridker PM (2004) Inflammation as a cardiovascular risk factor. Circulation 109(Supp 1):2–10 CrossRef
Xu J, Kochanek KD, Murphy SL, Tejada-Vera B (2007) Deaths: final data for 2007. Natl Vital Stat Rep 58:2010–2120
Are the elderly different?
Factors influencing mortality after percutaneous coronary intervention with stent implantation
Dr. J. Schröder